Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Dr. Vipul Wayal | Immunology and Microbiology| Excellence in Research Award

Postdoctoral Researcher at Tunghai University, Taiwan

Dr. Vipul Rohidas Wayal is a dynamic postdoctoral researcher specializing in biotechnology, translational medicine, and pharmaceutical sciences. Currently affiliated with Tunghai University in Taiwan, he has demonstrated exceptional expertise in bioactive peptides, metabolic diseases, and immunomodulation. His research has led to several high-impact publications and internationally recognized patents, reflecting strong innovation and translational potential. With a solid academic foundation—holding a Ph.D. in Animal Science and Biotechnology and a Master’s in Pharmaceutics—Dr. Wayal brings interdisciplinary proficiency across advanced bioinformatics, molecular docking, and animal modeling. He has actively contributed to projects targeting MAFLD, T2DM, and atherosclerosis and participated in global scientific forums such as BIO Asia and the Taiwan Innotech Expo. Recognized with scholarships and innovation awards, he is also skilled in scientific writing, grant proposals, and technology transfer. Dr. Wayal’s research impact and forward-thinking approach position him as a promising candidate for honors recognizing excellence in scientific research and innovation.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Dr. Vipul Rohidas Wayal has a robust academic background, reflecting a consistent focus on biomedical research and pharmaceutical sciences. He earned his Ph.D. in Animal Science and Biotechnology from Tunghai University, Taiwan, where his thesis explored the ameliorative effects of bioactive oligopeptides on metabolic-associated fatty liver disease (MAFLD) in murine models. His doctoral work integrated molecular biology, pharmacology, and biotechnology. Prior to this, he completed a Master of Pharmacy (M.Pharm) in Pharmaceutics from Rajiv Gandhi University of Health Sciences, Bangalore, India. His master’s thesis focused on the development of silk protein-based topical sprays for wound healing. Dr. Wayal also holds a Bachelor of Pharmacy from Savitribai Phule Pune University, India, where he conducted research on herbal gel formulations for wound healing. Throughout his education, he has cultivated expertise in drug delivery, biotechnology, and disease modeling, laying a solid foundation for translational research and pharmaceutical innovation.

Professional Experience

Dr. Wayal brings diverse professional experience, combining academic research with industrial roles. He currently serves as a postdoctoral researcher at Tunghai University, Taiwan, where he is involved in projects focusing on novel fermented foods, immunomodulators, and bioactive peptides for metabolic disorders such as NAFLD and T2DM. His earlier academic experience includes extensive work in molecular biology techniques, animal experimentation, and peptide-based therapeutic research. Before transitioning fully into academia, he held several positions in the pharmaceutical industry in India, including Factory Manager at Equine Nutrients and R&D Production Manager at Fibroheal Woundcare Pvt. Ltd., where he was involved in the development and manufacturing of wound-care products. Additionally, he worked as a Manufacturing Officer at Fresenius Kabi, handling large-scale pharmaceutical production. These roles have equipped him with hands-on expertise in technology transfer, quality control, and product development, giving him a practical perspective that complements his research endeavors.

Research Interest

Dr. Vipul Wayal’s research interests lie at the intersection of biotechnology, pharmaceutical sciences, and translational medicine. He is particularly focused on the discovery and functional evaluation of bioactive peptides and proteins for the prevention and treatment of metabolic diseases such as MAFLD, type 2 diabetes, and atherosclerosis. His work integrates molecular docking, bioinformatics, in vivo modeling, and immunological assays to uncover therapeutic pathways and mechanisms, particularly involving Nrf2/HO-1, TLR4/NF-κB, and inflammasome signaling. Additionally, he is involved in the development of functional foods with cardiovascular and immunomodulatory benefits. His broad skill set includes protein purification, ELISA, flow cytometry, and various forms of chromatography and spectroscopy, which support his bench-to-bedside research approach. Dr. Wayal also emphasizes innovative drug delivery systems, especially in peptide-based therapeutics, and is passionate about bridging the gap between laboratory discoveries and clinical applications through patentable, scalable solutions.

Award and Honor

Dr. Vipul Wayal has received recognition for both his academic performance and innovative research contributions. He was awarded the Tunghai University International Student Scholarship consecutively for the academic years 2021–2022 and 2022–2023, acknowledging his academic excellence and research productivity during his doctoral studies. One of his most notable achievements includes receiving the Excellent Idea Certificate for his patented innovation on “Novel Small Molecule Peptides for Anti-MAFLD Activity,” which has been granted in Taiwan and Japan and filed in the United States. His participation in international expos and conferences, such as the Taiwan Innotech Expo and BIO Asia–Taiwan, further emphasizes his growing international profile. These honors reflect his commitment to advancing science through novel and applicable innovations. While his accolades are notable, they also signal his potential for future recognition as his research continues to expand and influence both academic and applied biomedical fields.

Conclusion

In conclusion, Dr. Vipul Rohidas Wayal exemplifies a rising biomedical scientist with an impressive combination of academic excellence, industrial experience, and innovative research. His work in bioactive peptides, metabolic disease therapeutics, and functional food development has resulted in impactful publications and internationally recognized patents. He possesses a wide range of technical skills, from molecular biology to in silico modeling, supported by a solid educational foundation and cross-disciplinary collaborations. With experience spanning academia and pharmaceutical industries, Dr. Wayal effectively bridges fundamental research and real-world applications. His contributions demonstrate both scientific rigor and translational value, making him a strong contender for recognition such as the BExcellence in Research Award. As he continues to lead and contribute to projects addressing global health challenges, his trajectory indicates not only a promising research career but also the capacity to impact public health through innovation and scientific excellence.

Publications Top Notes

  • Title: Novel bioactive peptides alleviate Western diet-induced MAFLD…
    Authors: V. Wayal, S.D. Wang, C.C. Hsieh
    Journal: International Immunopharmacology 148
    Year: 2025
    Citations: 8

  • Title: Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced MAFLD…
    Authors: V. Wayal, C.C. Hsieh
    Journal: Biomedicine & Pharmacotherapy 168
    Year: 2023
    Citations: 7

  • Title: ASSESSMENT OF WOUND HEALING ACTIVITY OF POTENT HERBAL EXTRACTS GEL IN ALBINO WISTAR RAT
    Authors: V. Wayal, T.N.V.
    Journal: Asian Journal of Pharmaceutical and Clinical Research 15(08)
    Year: 2022
    Citations: 3

  • Title: Design, Development and Evaluation of Silk Based Film Forming Spray for Wound Healing
    Authors: V. Wayal, K. Nagasree, B.A. Vishwanath
    Journal: Journal of Drug Delivery & Therapeutics 11
    Year: 2021
    Citations: 3

  • Title: Chicken meat hydrolysate improves acetaminophen-induced liver injury…
    Authors: V. Wayal, Z.E. Tsai, Y.H. Lin, Y.H. Lai, S.D. Wang, C.C. Hsieh
    Journal: Journal of Agriculture and Food Research 21
    Year: 2025
    Citations: 1

  • Title: Immunomodulatory effects of type II arabinogalactans from Anoectochilus formosanus…
    Authors: Y.L. Huang, W.C. Lin, V. Wayal, C.C. Hsieh
    Journal: Carbohydrate Polymer Technologies and Applications
    Year: 2025

  • Title: Goat Whey Protein Hydrolysate Mitigates High-Fructose Corn Syrup-Induced Hepatic Steatosis…
    Authors: C.H. Shao, V. Wayal, C.C. Hsieh
    Journal: Preprints
    Year: 2025

  • Title: Type II Arabinogalactan from Anoectochilus Formosanus Dampens Allergic Airway Hyperresponsiveness…
    Authors: Y.L. Huang, V. Wayal, W.C. Lin, C.C. Hsieh
    Platform: SSRN Preprint
    Year: 2025

Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

Dr. Mohamed-Zakaria Assani | Immunology and Microbiology | Best Researcher Award

PhD Student at University of Medicine and Pharmacy of Craiova, Romania

Mohamed-Zakaria Assani is a dedicated and academically accomplished medical professional from Craiova, Romania. A graduate of the University of Medicine and Pharmacy of Craiova with a Doctor of Medicine degree, he is currently pursuing a PhD in Immunology, focusing on the implications of inflammation and atherosclerosis in chronic kidney disease. His academic excellence is reflected in his high GPAs and his master’s dissertation on population exposure to ionizing radiation. Mohamed-Zakaria has demonstrated leadership and community engagement through roles such as Project Coordinator for ONCOHELP and active volunteer work within student medical societies. He has participated in numerous congresses and clinical workshops, enhancing his practical and theoretical knowledge. Proficient in English and skilled in digital tools, he is well-equipped for research communication and collaboration. With a strong foundation in clinical research and a growing academic profile, he stands out as a promising early-career researcher committed to advancing medical science.

Professional Profile

ORCID Profile

Education

Mohamed-Zakaria Assani has an impressive academic background rooted in medical sciences. He graduated with a Doctor of Medicine (MD) degree from the University of Medicine and Pharmacy of Craiova, achieving an outstanding overall GPA of 9.69 and a dissertation exam GPA of 9.92. His academic excellence dates back to high school, where he earned a Baccalaureate GPA of 9.50 from the National College Frații Buzești in Craiova. Currently, he is pursuing a PhD in Immunology at the same university, where his research explores the interplay between inflammation, atherosclerosis, and chronic kidney disease—an area of critical importance in modern healthcare. His educational journey demonstrates consistent high performance, intellectual curiosity, and a solid foundation in both theoretical and practical aspects of medicine. He has also earned English language certifications (C1 level), further supporting his ability to engage with international research communities and access global academic resources effectively.

Professional Experience

Mohamed-Zakaria Assani has gained practical medical and leadership experience through a series of impactful roles. Currently, he serves as a resident in Laboratory Medicine at Filantropia Clinical Hospital and the Clinical Hospital of Neuropsychiatry in Craiova. These roles have enabled him to develop core diagnostic and analytical skills essential for laboratory-based and clinical research. Earlier in his academic journey, he demonstrated initiative and community engagement as a project coordinator for ONCOHELP within SSM Craiova and as a volunteer for various student-led projects, including TRANSMED and university-wide events such as the Freshman Ball. His participation in medical workshops and congresses—like the Annual Congress of Surgery for Students and CIMSC—further underscores his dedication to continuous professional development. These experiences have not only broadened his clinical perspective but also allowed him to build strong interpersonal and organizational skills, both crucial for team-based medical research and healthcare practice.

Research Interest

Mohamed-Zakaria Assani’s research interests lie at the intersection of immunology, cardiovascular pathology, and nephrology, focusing specifically on how inflammation and atherosclerosis contribute to chronic kidney disease (CKD). This multidisciplinary approach highlights his commitment to understanding complex disease mechanisms and improving patient outcomes through evidence-based research. His PhD work delves into the cellular and molecular pathways that drive disease progression in CKD, a pressing global health challenge. Additionally, his master’s dissertation explored population exposure to ionizing radiation from high-performance radiological investigations, demonstrating his early concern for public health and medical safety. Mohamed-Zakaria is driven by a desire to bridge laboratory findings with clinical applications, and his work holds the potential to inform diagnostic tools, therapeutic strategies, and preventive measures. His research aims not only to contribute new knowledge to the scientific community but also to enhance clinical practice, particularly in the management of chronic and systemic diseases.

Award and Honor

Although specific formal awards are not listed, Mohamed-Zakaria Assani’s academic record and extracurricular achievements position him as a strong candidate for recognition in research and leadership. Graduating with distinction from both high school and medical school, and earning high scores on his dissertation, he has consistently demonstrated academic excellence. His selection as a Project Coordinator within SSM Craiova for the ONCOHELP initiative, along with his active participation in prestigious student congresses such as CIMSC and the Annual Congress of Surgery, reflects peer and institutional acknowledgment of his capabilities. He also holds English proficiency certifications (Cambridge C1), further validating his readiness for international academic participation. His combination of scholarly commitment, volunteer service, and leadership roles speaks to a well-rounded and motivated individual deserving of early-career honors, such as young researcher awards or medical innovation fellowships. His profile illustrates promise and preparedness for future accolades in the field of medical research.

Conclusion

In conclusion, Mohamed-Zakaria Assani is a highly motivated and capable early-career medical researcher with a commendable blend of academic achievement, clinical experience, and leadership involvement. His educational accomplishments and current doctoral work in immunology place him at the forefront of critical research on chronic kidney disease. He has proactively contributed to both academic and volunteer communities, showing a strong sense of responsibility and dedication to healthcare. While he would benefit from expanding his research portfolio through publications and international collaborations, his foundational strengths are undeniable. With a clear focus on impactful, multidisciplinary research and a history of academic excellence, he is exceptionally well-positioned to contribute to the future of medical science. He is a promising candidate for research awards and a strong example of emerging talent in laboratory and clinical medicine. His continued progress will no doubt lead to significant contributions in the medical and scientific fields.

Publications Top Notes

1. Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients

  • Authors: Roxana-Viorela Ahrițculesei, Lidia Boldeanu, Daniel Cosmin Caragea, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Anca Marilena Ungureanu, Constantin Cristian Văduva, Anda Lorena Dijmărescu, Alin Iulian Silviu Popescu, et al.

  • Year: 2025

  • Citation: Ahrițculesei, R.-V., Boldeanu, L., Caragea, D. C., Vladu, M., Clenciu, D., Mitrea, A., Ungureanu, A. M., Văduva, C. C., Dijmărescu, A. L., Popescu, A. I. S., et al. (2025). Association Between Pentraxins and Obesity in Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus Patients. International Journal of Molecular Sciences, 26(8), 3661. https://doi.org/10.3390/ijms26083661

2. Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy

  • Authors: Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Constantin Cristian Văduva, Mihaela Vladu, Diana Clenciu, Adina Mitrea, Roxana-Viorela Ahrițculesei, Alexandra-Ștefania Stroe-Ionescu, Alexandru-Dan Assani, et al.

  • Year: 2025

  • Citation: Assani, M.-Z., Novac, M. B., Dijmărescu, A. L., Văduva, C. C., Vladu, M., Clenciu, D., Mitrea, A., Ahrițculesei, R.-V., Stroe-Ionescu, A.-Ș., Assani, A.-D., et al. (2025). Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy. Nutrients, 17(8), 1339. https://doi.org/10.3390/nu17081339

3. Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania

  • Authors: I. Prejbeanu, M. Z. Assani, F. Niculescu, L. A. Prunariu, R. G. Prejbeanu

  • Year: 2024

  • Citation: Prejbeanu, I., Assani, M. Z., Niculescu, F., Prunariu, L. A., & Prejbeanu, R. G. (2024). Radiation Exposure of Patients Undergoing Multiple-Slice CT Scans in Romania. European Journal of Public Health, 34(Supplement 1), ckae144.2140. https://doi.org/10.1093/eurpub/ckae144.2140